Literature DB >> 25606104

Understanding patient management: the need for medication adherence and persistence.

Yc Chia1.   

Abstract

Poor patient adherence to medication is one of the major factors contributing to poor disease control, in particular in asymptomatic chronic diseases like hypertension and dyslipidaemia. The physical and economic burden on patients and the health care system as a result of non-adherence is great. It is estimated that poor adherence to hypertension medication accounts for as many as 7.1 million preventable deaths annually. Hence recognising and identifying non-adherence is the first step to addressing this problem. Medication adherence can be measured in various ways including self-report to electronic monitoring. In order to be more successful in managing non-adherence, attention must be paid to barriers to adherence, namely the interplay of patient factors, the health care providers themselves and the health care system itself. Taking these into account will probably have the greatest impact on improving medication adherence. Consequently strategies to help overcome these barriers are of paramount importance. Some of these strategies will include education of patients, improving communication between patients and health care providers, improving dose scheduling, providing drugs with less adverse effects, and improving accessibility to health care. Poor mediation adherence continues to be a huge challenge. While the patient is ultimately responsible for the taking of medication, good communication, involving the patient in decision making about their care and simplifying drug regimens go a long way in improving it.

Entities:  

Keywords:  Compliance; medication adherence

Year:  2008        PMID: 25606104      PMCID: PMC4267031     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  22 in total

1.  A systematic review of the associations between dose regimens and medication compliance.

Authors:  A J Claxton; J Cramer; C Pierce
Journal:  Clin Ther       Date:  2001-08       Impact factor: 3.393

Review 2.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

Review 3.  Medication adherence and persistence as the cornerstone of effective antihypertensive therapy.

Authors:  Michel Burnier
Journal:  Am J Hypertens       Date:  2006-11       Impact factor: 2.689

4.  How often is medication taken as prescribed? A novel assessment technique.

Authors:  J A Cramer; R H Mattson; M L Prevey; R D Scheyer; V L Ouellette
Journal:  JAMA       Date:  1989-06-09       Impact factor: 56.272

5.  Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study.

Authors:  B Waeber; G Leonetti; R Kolloch; G T McInnes
Journal:  J Hypertens       Date:  1999-07       Impact factor: 4.844

6.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.

Authors:  V L Burt; P Whelton; E J Roccella; C Brown; J A Cutler; M Higgins; M J Horan; D Labarthe
Journal:  Hypertension       Date:  1995-03       Impact factor: 10.190

7.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

8.  Predicting compliance with a regimen of digoxin therapy in family practice.

Authors:  J R Gilbert; C E Evans; R B Haynes; P Tugwell
Journal:  Can Med Assoc J       Date:  1980-07-19       Impact factor: 8.262

Review 9.  Monitoring compliance in resistant hypertension: an important step in patient management.

Authors:  Michel Burnier; Valérie Santschi; Bernard Favrat; Hans R Brunner
Journal:  J Hypertens Suppl       Date:  2003-05

Review 10.  Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review.

Authors:  Gwenn E C Wetzels; Patty Nelemans; Jan S Schouten; Martin H Prins
Journal:  J Hypertens       Date:  2004-10       Impact factor: 4.844

View more
  2 in total

1.  Hydroxyurea Initiation Among Children With Sickle Cell Anemia.

Authors:  Sarah L Reeves; Hannah K Jary; Jennifer P Gondhi; Jean L Raphael; Lynda D Lisabeth; Kevin J Dombkowski
Journal:  Clin Pediatr (Phila)       Date:  2019-05-21       Impact factor: 1.168

2.  Patient Compliance: Fact or Fiction?

Authors:  A K Mohiuddin
Journal:  Innov Pharm       Date:  2019-08-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.